Skip to main content

Biventricular Failure

0
Pipeline Programs
1
Companies
2
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

1 companies ranked by most advanced pipeline stage

SynCardia Systems
2 programs
CardioWest temporary Total Artificial HeartN/A1 trial
CardioWest temporary Total Artificial HeartN/A1 trial
Active Trials
NCT00733447Approved For MarketingEst. May 2014
NCT00614510Completed196Est. Mar 2015

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
SynCardia SystemsCardioWest temporary Total Artificial Heart
SynCardia SystemsCardioWest temporary Total Artificial Heart

Clinical Trials (2)

Total enrollment: 196 patients across 2 trials

NCT00733447SynCardia SystemsCardioWest temporary Total Artificial Heart

SynCardia Freedom Driver System Study

Start: Mar 2010Est. completion: May 2014
N/AApproved For Marketing
NCT00614510SynCardia SystemsCardioWest temporary Total Artificial Heart

SynCardia CardioWest TAH-t Postmarket Surveillance Study

Start: Aug 2006Est. completion: Mar 2015196 patients
N/ACompleted

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

1 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.